Apmonia Therapeutics

Developer of peptide-based therapeutics for cancer

placeReims, Grand Est, France calendar_todayFounded 2019 groups11 employees language apmonia-therapeutics.com

Social engagement

Social engagement: 4.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include European Innovation Council.

Investor typeCountShare
Venture capital125%
Private equity125%
Bank & private debt125%
Other / undisclosed125%

Recent activity

24 Jun 2026
Event
BIO International Convention 2026
17 Jun 2026
Milestone
regulatory
12 Jun 2026
Event
2026 President's Meeting of the International Society of Quantum Biology and Pharmacology (ISQBP)
Coming soon